Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-21-150583
Filing Date
2021-12-16
Accepted
2021-12-16 17:15:28
Documents
16
Period of Report
2021-12-15
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2135560d2_8ka.htm   iXBRL 8-K/A 34559
2 EXHIBIT 23.1 tm2135560d2_ex23-1.htm EX-23.1 2498
3 EXHIBIT 99.1 tm2135560d2_ex99-1.htm EX-99.1 72801
4 EXHIBIT 99.2 tm2135560d2_ex99-2.htm EX-99.2 68512
5 EXHIBIT 99.3 tm2135560d2_ex99-3.htm EX-99.3 280717
  Complete submission text file 0001104659-21-150583.txt   683552

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA asrt-20211215.xsd EX-101.SCH 3031
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE asrt-20211215_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asrt-20211215_pre.xml EX-101.PRE 22363
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2135560d2_8ka_htm.xml XML 4103
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39294 | Film No.: 211498514
SIC: 2834 Pharmaceutical Preparations